Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Low alkaline phosphatase (ALP) allows inorganic pyrophosphate to build up in joints, where it binds calcium and forms CPPD crystals that inflame the synovium, erode cartilage, and trigger pseudogout attacks and early osteoarthritis, most often in adults with mild hypophosphatasia (ALPL gene variants) or with zinc, magnesium, or B12 deficiency, hypothyroidism, celiac disease, or bisphosphonate use. Doctor next steps typically include repeat ALP with age and sex specific ranges, vitamin B6 and urine phosphoethanolamine testing, joint imaging for chondrocalcinosis, and referral to rheumatology or a metabolic bone specialist, since treatment differs sharply depending on the underlying cause. There are several important factors and red flags to consider, including which medications can worsen cartilage loss, so see below to understand more.
Because joint pain, stiffness, fractures, and dental loss can point to very different conditions, a few minutes spent describing your symptoms clearly can help you and your doctor focus on the right tests first. Take a free, instant, online symptom check to better understand what may be driving your symptoms and how to navigate next steps.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme found throughout your body that plays a key role in bone and cartilage health. When alk phos levels are low, a rare condition called hypophosphatasia can develop, leading to weakened bones and joint cartilage destruction. This guide explains why low ALP harms cartilage, how to recognize it, and what your doctor may recommend next.
Alkaline phosphatase helps regulate mineral balance by:
When ALP activity dips below normal, PPi accumulates. Excess PPi prevents proper mineral deposition in cartilage and bone. Instead of strengthening, your cartilage becomes soft, prone to fissures and breakdown.
Your care team will tailor treatment to the severity of enzyme deficiency and joint damage:
Although low ALP itself rarely causes sudden emergencies, watch for:
If any of these occur, speak to a doctor or go to the nearest emergency department.
Not sure if your joint discomfort is tied to low alk phos levels or another issue? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps before you see your provider.
Low alkaline phosphatase can quietly undermine cartilage health by allowing pyrophosphate buildup, blocking mineralization, and triggering inflammation. Early recognition, accurate diagnosis, and targeted therapy—ranging from nutritional support to enzyme replacement—can slow or halt joint destruction. Always work closely with a medical team to monitor labs, manage symptoms, and decide on specialist referrals.
If you’re experiencing unexplained joint pain or stiffness, or you have confirmed low alk phos levels, don’t wait. Speak to your doctor about testing, potential treatments, and any new or worsening symptoms. Proper intervention today can protect your joints and improve your quality of life tomorrow.
(References)
* Rubinstein HM, Shah DM. Pseudogout. Semin Arthritis Rheum. 1972-1973;2(3):259-80. doi: 10.1016/0049-0172(72)90011-x. PMID: 4354552.
* Eade AW, Swannell AJ, Williamson N. Pyrophosphate arthropathy in hypophosphatasia. Ann Rheum Dis. 1981 Apr;40(2):164-70. doi: 10.1136/ard.40.2.164. PMID: 6261701; PMCID: PMC1000700.
* Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS. Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab. 1996 Jun;81(6):2142-8. doi: 10.1210/jcem.81.6.8964842. PMID: 8964842.
* Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc. 2009 Oct;84(10):893-902. doi: 10.4065/84.10.893. PMID: 19797778; PMCID: PMC2755808.
* Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis--role of ANKH. Nat Rev Rheumatol. 2011 Feb;7(2):96-104. doi: 10.1038/nrrheum.2010.182. Epub 2010 Nov 23. PMID: 21102543.
* Chang CY, Rosenthal DI, Mitchell DM, Handa A, Kattapuram SV, Huang AJ. Imaging Findings of Metabolic Bone Disease. Radiographics. 2016 Oct;36(6):1871-1887. doi: 10.1148/rg.2016160004. PMID: 27726750.
* Amadeu de Oliveira F, Narisawa S, Bottini M, Millán JL. Visualization of Mineral-Targeted Alkaline Phosphatase Binding to Sites of Calcification In Vivo. J Bone Miner Res. 2020 Sep;35(9):1765-1771. doi: 10.1002/jbmr.4038. Epub 2020 May 8. PMID: 32343017; PMCID: PMC8383212.
* Sawamoto K, Álvarez JV, Herreño AM, Otero-Espinar FJ, Couce ML, Alméciga-Díaz CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 Oct;18(5):515-525. doi: 10.1007/s11914-020-00620-4. PMID: 32845464; PMCID: PMC7541793.
* Thrailkill KM, Kalaitzoglou E, Fowlkes JL. Emerging therapies for the treatment of rare pediatric bone disorders. Front Pediatr. 2022;10:1012816. doi: 10.3389/fped.2022.1012816. Epub 2022 Oct 11. PMID: 36304528; PMCID: PMC9592743.
* Pascart T, Filippou G, Lioté F, Sirotti S, Jauffret C, Abhishek A. Calcium pyrophosphate deposition disease. Lancet Rheumatol. 2024 Nov;6(11):e791-e804. doi: 10.1016/S2665-9913(24)00122-X. Epub 2024 Jul 29. PMID: 39089298.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.